<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="ted/R2.0.8.S03/publication" xmlns:n2016="ted/2016/nuts" xsi:schemaLocation="ted/R2.0.8.S03/publication TED_EXPORT.xsd" DOC_ID="192448-2018" EDITION="2018085"><TECHNICAL_SECTION><RECEPTION_ID>18-195142-001</RECEPTION_ID><DELETION_DATE>20180808</DELETION_DATE><FORM_LG_LIST>PT </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple " xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>85</NO_OJ><DATE_PUB>20180503</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2018/S 085-192448</NO_DOC_OJS><URI_LIST><URI_DOC LG="PT">http://ted.europa.eu/udl?uri=TED:NOTICE:192448-2018:TEXT:PT:HTML</URI_DOC></URI_LIST><LG_ORIG>PT</LG_ORIG><ISO_COUNTRY VALUE="PT"/><IA_URL_GENERAL/><ORIGINAL_CPV CODE="33651520">Immunoglobulins</ORIGINAL_CPV><VALUES_LIST><VALUES TYPE="GLOBAL"><SINGLE_VALUE><VALUE CURRENCY="EUR">163 716,00</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="EUR">163 716,00</VALUE></SINGLE_VALUE></VALUES></VALUES_LIST></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20180430</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="6">Accelerated negotiated procedure</PR_PROC><RP_REGULATION CODE="4">European Union</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="Z">Not specified</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01203</HEADING><DIRECTIVE VALUE="2004/18/EC"/></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Пopтyгaлия</TI_CY><TI_TOWN>Лисабон</TI_TOWN><TI_TEXT>Имуноглобулини</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Portugalsko</TI_CY><TI_TOWN>Lisabon</TI_TOWN><TI_TEXT>Imunoglobuliny</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Portugal</TI_CY><TI_TOWN>Lissabon</TI_TOWN><TI_TEXT>Immunoglobuliner</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Portugal</TI_CY><TI_TOWN>Lissabon</TI_TOWN><TI_TEXT>Immunglobuline</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Πορτογαλία</TI_CY><TI_TOWN>Λισσαβόνα</TI_TOWN><TI_TEXT>Ανοσοσφαιρίνες</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Portugal</TI_CY><TI_TOWN>Lisbon</TI_TOWN><TI_TEXT>Immunoglobulins</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>Portugal</TI_CY><TI_TOWN>Lisboa</TI_TOWN><TI_TEXT>Inmunoglobulinas</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Portugal</TI_CY><TI_TOWN>Lissabon</TI_TOWN><TI_TEXT>Immuunglobuliinid</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Portugali</TI_CY><TI_TOWN>Lissabon</TI_TOWN><TI_TEXT>Immunoglobuliinit</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Portugal</TI_CY><TI_TOWN>Lisbonne</TI_TOWN><TI_TEXT>Immunoglobulines</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Phortaingéil, an</TI_CY><TI_TOWN>Liospóin</TI_TOWN><TI_TEXT>Immunoglobulins</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Portugal</TI_CY><TI_TOWN>Lisabon</TI_TOWN><TI_TEXT>Imunoglobini</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Portugália</TI_CY><TI_TOWN>Lisszabon</TI_TOWN><TI_TEXT>Immunglobulin</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Portogallo</TI_CY><TI_TOWN>Lisbona</TI_TOWN><TI_TEXT>Immunoglobuline</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Portugalija</TI_CY><TI_TOWN>Lisabona</TI_TOWN><TI_TEXT>Imunoglobulinai</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Portugāle</TI_CY><TI_TOWN>Lisabona</TI_TOWN><TI_TEXT>Imūnglobulīni</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>il-Portugall</TI_CY><TI_TOWN>Liżbona</TI_TOWN><TI_TEXT>Immunoglobulini</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Portugal</TI_CY><TI_TOWN>Lissabon</TI_TOWN><TI_TEXT>Immunoglobulinen</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Portugalia</TI_CY><TI_TOWN>Lizbona</TI_TOWN><TI_TEXT>Immunoglobuliny</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Portugal</TI_CY><TI_TOWN>Lisboa</TI_TOWN><TI_TEXT>Imunoglobulinas</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Portugalia</TI_CY><TI_TOWN>Lisabona</TI_TOWN><TI_TEXT>Imunoglobuline</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Portugalsko</TI_CY><TI_TOWN>Lisabon</TI_TOWN><TI_TEXT>Imunoglobulíny</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Portugalska</TI_CY><TI_TOWN>Lizbona</TI_TOWN><TI_TEXT>Imunoglobulini</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Portugal</TI_CY><TI_TOWN>Lissabon</TI_TOWN><TI_TEXT>Antikroppar</TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="PT">Centro Hospitalar Lisboa Norte, E. P. E.</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><CONTRACT_AWARD CATEGORY="ORIGINAL" FORM="3" LG="PT" VERSION="R2.0.8.S03.E01"><FD_CONTRACT_AWARD CTYPE="SUPPLIES"><CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><CA_CE_CONCESSIONAIRE_PROFILE><ORGANISATION><OFFICIALNAME>Centro Hospitalar Lisboa Norte, E. P. E.</OFFICIALNAME></ORGANISATION><ADDRESS>Lisboa</ADDRESS><TOWN>Lisboa</TOWN><POSTAL_CODE>1649-035</POSTAL_CODE><COUNTRY VALUE="PT"/></CA_CE_CONCESSIONAIRE_PROFILE><INTERNET_ADDRESSES_CONTRACT_AWARD/></NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF><TYPE_AND_ACTIVITIES><TYPE_OF_CONTRACTING_AUTHORITY VALUE="BODY_PUBLIC"/><TYPE_OF_ACTIVITY VALUE="HEALTH"/></TYPE_AND_ACTIVITIES><PURCHASING_ON_BEHALF><PURCHASING_ON_BEHALF_NO/></PURCHASING_ON_BEHALF></TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF></CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><DESCRIPTION_AWARD_NOTICE_INFORMATION><TITLE_CONTRACT><P>Ajuste direto número 181G001647 — Aquisição de imunoglobulina</P></TITLE_CONTRACT><TYPE_CONTRACT_LOCATION_W_PUB><TYPE_CONTRACT VALUE="SUPPLIES"/></TYPE_CONTRACT_LOCATION_W_PUB><SHORT_CONTRACT_DESCRIPTION><P>Aquisição de imunoglobulina 100mg/ml injectável fração 100ml.</P></SHORT_CONTRACT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33651520"/></CPV_MAIN></CPV></DESCRIPTION_AWARD_NOTICE_INFORMATION><TOTAL_FINAL_VALUE><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="163716.00">163 716,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></TOTAL_FINAL_VALUE></OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><TYPE_OF_PROCEDURE_DEF><PT_ACCELERATED_NEGOTIATED/></TYPE_OF_PROCEDURE_DEF></PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><AWARD_OF_CONTRACT><CONTRACT_AWARD_DATE><DAY>20</DAY><MONTH>04</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>CSL Behring, Lda.</OFFICIALNAME></ORGANISATION></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="163716.00">163 716,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION></AWARD_OF_CONTRACT><COMPLEMENTARY_INFORMATION_CONTRACT_AWARD><NOTICE_DISPATCH_DATE><DAY>30</DAY><MONTH>04</MONTH><YEAR>2018</YEAR></NOTICE_DISPATCH_DATE></COMPLEMENTARY_INFORMATION_CONTRACT_AWARD></FD_CONTRACT_AWARD></CONTRACT_AWARD></FORM_SECTION></TED_EXPORT>